The U.S. Senate Committee on Aging will convene a panel tomorrow, April 13, 2011, to hear testimony about the DePuy Hip Implant Recall tomorrow, April 13, 2011.
Testifying before the Senate will be leading patient safety advocates, including Diana Zuckerman, the co-author of a report that claims that medical devices that were approved by the FDA through the 510(k) program are more commonly recalled. The recalled DePuy ASR XL Acetabular and Hip Resurfacing Systems were brought to the market without having gone through clinical trials under the FDA rule 510.
Other experts will also testify including Dr. William Maisel, chief science officer for the FDA’s Center for Devices & Radiological Health; David Nexon of the Advanced Medical Technology Association; and Ralph Hall, a professor at the University of Minnesota Law School.
Also appearing before the committee will be a patient who was affected by the recall.
DePuy announced their voluntary recall of their ASR hip implant systems in August 2010 after reports that patients with these devices were experiencing failure at a rate higher than other medical devices. Since then, there is a growing concern that, because of the design of the hip, there is a risk of metal-on-metal rubbing which can release ions of cobalt and chromium in the blood system and surrounding tissues resulting in serious side effects including metallosis.
Many patients have filed lawsuits against DePuy claiming damages after having to undergo a second, or revision, surgery. In addition, patients who are at this time asymptomatic need to have their blood drawn and tested for the presence of metals. Many of these patients are choosing to contact a personal injury attorneys who specialize in product liability to insure their rights are protected.
This information is provided by Washington Injury Attorney blog, a service of The Farber Law Group. We represent patients who received a defective DePuy ASR hip. The founder of our law firm, Herb Farber, is himself a hip replacement patient so he is keenly aware of the trauma of a revision surgery.
FDA releases information for patients with metal-on-metal hip implants
Contact The Farber Law Group at 1-800-244-9087 or email@example.com to schedule a free and confidential case evaluation. We have offices in Seattle and Bellevue to assist you.